Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy
Cancer Medicine · 2025
DOI: 10.1002/cam4.71429 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, 2025. Verfasst von Yao Xiao und 2 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Memory T Cells, Immunologic Memory. Die Arbeit nennt 131 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities, Hubei Province International Science and Technology Cooperation Project.
Abstract (Originalsprache)
Background
Tissue‐resident memory T cells (T RM ) are a specialized subset of memory T cells that reside in nonlymphoid tissues and draining lymph nodes, playing a critical role in immune surveillance and tumor immunity. Tumor‐infiltrated T RM have emerged as key players in immune checkpoint blockade (ICB) therapy, contributing to early therapeutic responses and tumor control.
Aims
This review aims to comprehensively summarize the identification, functional roles, and regulatory mechanisms of T RM in the context of tumor immunity, and to explore innovative strategies for enhancing T RM ‐mediated anti‐tumor responses.
Methods
We reviewed recent literature on T RM biology, focusing on their transcriptional regulation, phenotypic characteristics, and interactions within the tumor microenvironment. We also reviewed current strategies for modulating T RM function to improve cancer immunotherapy outcomes.
Results
T RM can remodel the tumor microenvironment, suppress tumor progression, and enhance ICB efficacy. Their function is tightly regulated by transcription factors and phenotypic molecules. Targeted manipulation of these regulatory mechanisms has shown potential in enhancing T RM /T RM ‐like cell activity and overcoming resistance to ICB therapy.
Conclusion
T RM represent a promising target for cancer immunotherapy due to their potent anti‐tumor functions and responsiveness to ICB. Understanding their biology and regulatory networks opens new avenues for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Frontier Sci…
- Department of Oral Maxillofacial-Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
ORCID-Profile: Zhi-Jun Sun
Förderung
- National Natural Science Foundation of China
- Fundamental Research Funds for the Central Universities
- Hubei Province International Science and Technology Cooperation Project
Zitieren
APA
Xiao, Y., Yang, Q. C., & Sun, Z. J. (2025). Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy. Cancer Medicine. https://doi.org/10.1002/cam4.71429
Vancouver
Xiao Y, Yang QC, Sun ZJ. Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy. Cancer Medicine. 2025. doi:10.1002/cam4.71429
BibTeX
@article{Xiao2025,
author = {Xiao, Yao and Yang, Qi-Chao and Sun, Zhi-Jun},
title = {Tissue‐Resident Memory T Cells: Pioneering New Avenues in Cancer Immunotherapy},
journal = {Cancer Medicine},
year = {2025},
doi = {10.1002/cam4.71429}
}
EUVIMED